Algorics’ VP Clinical Solutions Abby Abraham is to join the expert panel at the upcoming 2nd Indian Cancer Congress taking place in Bengaluru from 8-12 November.  Abby will join other industry experts in the Clinical Trials stream from 9:15 AM in the session titled, ‘ICH GCP (R2): Its impact on how trials will be run’ on Thursday 9 November.  Following an initial industry presentation focused on the regulatory impact of ICH GCP R2, the panel will tackle the topic of how things have changed, how they will impact global clinical trials and will debate ‘Risk Based Monitoring: the Pros and Cons from an Auditor’s Perspective’.

Join us and be part of the discussion.

For registration and more event information, check here

.